Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02365948
Recruitment Status : Completed
First Posted : February 19, 2015
Last Update Posted : August 14, 2015
Information provided by (Responsible Party):
UCB Pharma ( UCB Pharma SA )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2015
Actual Study Completion Date : August 2015